Literature DB >> 15733016

5-Lipoxygenase as a putative mechanism of NSAID-related psychiatric adverse events.

Radmila Manev, Hari Manev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15733016     DOI： 10.2165/00003495-200565040-00009

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  6 in total

1.  Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.

Authors:  Johanne Martel-Pelletier; François Mineau; Hassan Fahmi; Stefan Laufer; Pascal Reboul; Christelle Boileau; Martin Lavigne; Jean-Pierre Pelletier
Journal:  Arthritis Rheum       Date:  2004-12

2.  5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders.

Authors:  Radmila Manev; Hari Manev
Journal:  Crit Rev Neurobiol       Date:  2004

Review 3.  NSAID-related psychiatric adverse events: who is at risk?

Authors:  Graziano Onder; Francesca Pellicciotti; Giovanni Gambassi; Roberto Bernabei
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior.

Authors:  Tolga Uz; Nikola Dimitrijevic; Patricia Tueting; Hari Manev
Journal:  Restor Neurol Neurosci       Date:  2002       Impact factor: 2.406

5.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.

Authors:  Anna Helgadottir; Andrei Manolescu; Gudmar Thorleifsson; Solveig Gretarsdottir; Helga Jonsdottir; Unnur Thorsteinsdottir; Nilesh J Samani; Gudmundur Gudmundsson; Struan F A Grant; Gudmundur Thorgeirsson; Sigurlaug Sveinbjornsdottir; Einar M Valdimarsson; Stefan E Matthiasson; Halldor Johannsson; Olof Gudmundsdottir; Mark E Gurney; Jesus Sainz; Margret Thorhallsdottir; Margret Andresdottir; Michael L Frigge; Eric J Topol; Augustine Kong; Vilmundur Gudnason; Hakon Hakonarson; Jeffrey R Gulcher; Kari Stefansson
Journal:  Nat Genet       Date:  2004-02-08       Impact factor: 38.330

6.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.

Authors:  James H Dwyer; Hooman Allayee; Kathleen M Dwyer; Jing Fan; Huiyun Wu; Rebecca Mar; Aldons J Lusis; Margarete Mehrabian
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.